Helix and Recursion Pharmaceuticals Drive Drug Discovery Innovation Through Clinico-Genomic Data
Go back to Helix and Recursion Pharmaceuticals Drive Drug Discovery Innovation Through Clinico-Genomic Data| (NASDAQ: RXRX) | Delayed: 4.27 -0.36 (7.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.63 | 52 Week High | $ | |||
| Open | $4.51 | 52 Week Low | $ | |||
| Day High | $4.60 | P/E | N/A | |||
| Day Low | $4.23 | EPS | $ | |||
| Volume | 40,723,529 | |||||



